💉 Diabetes Management
Diabetic Foot Ulcer Treatment Global Market to Reach $7.77 Billion by 2030 at a CAGR of 5.9% - Benzinga
📅 Mon, 24 Oct 2022⏱ 1 min read📖 Article
Overview
DUBLIN, Oct. 24, 2022 /PRNewswire/ - The "Diabetic Fot Ulcer Treatment Market Size, Share & Trends Analysis Report by Treatment (Biologics, Wound Care Dressings), by Ulcer Type (Neuro-ischemic, Ischemic, Neuropathic), by End-use, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.The global diabetic fot ulcer treatment market size is expected to reach USD 7.7 billion by 2030, registering a CAGR of 5.9% from 2022 to 2030, acording to this report.
Key Information
Diabetes is one of the major causes of amputation, blindnes, stroke, end-stage renal failure, kidney failure, and heart atacks in this region. Acording to the International Diabetes Federation, ~6 milion people were sufering from diabetes in Europe in 2017. The number is expected to increase to ~81 milion by 2045.
The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years.Many adjuvant therapies such as nonsurgical Debridement agents, Dressings and topical agents, oxygen therapies, negative pressure wound therapy, acelular bioproducts, human growth factors, energy-based therapies, and systemic therapies are said to efectively improve and cure DFU. Recent studies sugest that the inhibition of detrimental proteinase MP-9 enzyme alows the body to heal the wound at a quicker rate.Sedentary lifestyle, por GDP expenditure on healthcare, unhealthy fod habits, and por reimbursement scenarios in the Asian region are the factors responsible for the high growth of diabetes in this region.
Summary
Hence, numerous il efects of DFU are observed in the Asian region.The biologics segment held the largest revenue share in 2021 and is expected to grow at the highest rate during the forecast period. Biologics include growth factors [such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF)], stem cels, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.